InsightfulValue
← Home

Novartis
Novartis

Pharma / Pharmaceuticals and Healthcare


πŸ”§ Tools

βœ… Due Diligence
πŸ“Œ Key Metrics

Pay attention and research significant changes from year to year values. [ ! ]

Market CapEnterprise ValueNet Income Per ShareRevenue Per ShareOperating Cash Flow
Per Share
Free Cash Flow
Per Share
Cash Per ShareBook Value
Per Share
Shareholders Equity
Per Share
Tangible Book Value
Per Share
Tangible Asset ValueNet Current Asset ValueWorking CapitalInvested CapitalROEROICReturn On Tangible AssetsIncome QualityDebt To EquityDebt To AssetsNet Debt To EBITDAInterest Debt
Per Share
Interest CoverageP/E RatioEarnings YieldPrice To Sales RatioPFCF RatioPOCF ratioP/B RatioPTB RatioEV To Operating
Cash Flow
EV To Free Cash FlowEV To SalesEnterprise Value
Over EBITDA
Free Cash Flow YieldDividend YieldPayout RatioCAPEX Per ShareCAPEX To Operating Cash FlowCAPEX To RevenueCAPEX To DepreciationSales General And
Administrative To Revenue
R&D To RevenueStock Based
Compensation To Revenue
Current RatioDays Sales OutstandingDays Payables OutstandingDays Of Inventory On HandReceivables TurnoverPayables TurnoverInventory TurnoverAverage ReceivablesAverage PayablesAverage InventoryGraham NumberGraham Net-NetIntangables To
Total Assets
2024-12196.504 B216.303 B5.93489065606361825.7067594433399628.7569582504970186.8613320079522866.63568588469184921.93141153081510821.891650099403577 -3.75 -7.545 B -28.416 B 1.012 B63.556 B0.27110293783771510.155478457004803420.236104794859120121.47575173800150770.70966716614448530.30571367095045280.955780835143615816.0357852882703814.45725646123260516.4562081527510280.060767340247384223.79922627802482614.234232636870711.1529361230489834.4613263758797634.46132637587976312.27666618718429215.6684231475552364.18202276694636810.4418335289403820.070253172440762010.0387982750226997240.63847248974122771.89562624254473170.2164708553266360.073740381269092450.62843961113857300.19376667568926180.020184834306484671.035271155722849667.31632574146398130.0990099009901162.851407187962885.4221616521647972.80555555555555542.2413070068146089.458 B4.749 B5.818 B54.067572226494505 -17.27298707753479 0.5053596228703323
2023-12210.931 B223.886 B7.10609243888235522.3279645251347256.9185107394855955.6011321210180446.6811624667794922.3710317520370422.3313141983382370.88957749790453181.859 B -22.714 B 4.091 B59.906 B0.318212012771337370.114925486329529410.269735169106695261.68665422305179650.5645959671716630.26362499374656060.709668583949602913.01730859359708211.42573099415204814.2041342507324870.07040203805088874.520604235391715518.0206231203227214.5892511843531224.5199261495998774.51992614959987715.48529489717647319.1274150895666324.79825104207838512.2643874896399580.055491976793646610.034395069768296120.488552188552188571.31737861846755020.190413611841195180.059001285897985430.3326084330071281700.24369909987141020.018538362623231891.155020841227737873.3441920274325144.16212315586915173.04722578576014.9765358361774742.5318717011774262.109250803314739.635 B5.036 B6.544 B59.75356572573845 -13.994216857164647 0.4491570363700035
2022-12************************************************************************************************************************************************************************************************************************************
2021-12************************************************************************************************************************************************************************************************************************************
2020-12************************************************************************************************************************************************************************************************************************************
2019-12************************************************************************************************************************************************************************************************************************************
2018-12************************************************************************************************************************************************************************************************************************************
2017-12************************************************************************************************************************************************************************************************************************************
2016-12************************************************************************************************************************************************************************************************************************************
Novartis

πŸ“Š Explore more key metrics for Novartis!

Sign up for free or log in

πŸ”“ Unlock our free guide: "The Checklist Value Investor β€” A Smarter Way to Pick Stocks"

© 2024 - 2025 InsightfulValue.com. All rights reserved. Newsletter
Legal